Catalog No.
Product Name
Application
Product Information
Product Citation
-
Oxytocin Receptor Antagonist
Retosiban (GSK-221,149-A) is an oral drug which acts as a selective, sub-nanomolar (Ki = 0.65 nM) oxytocin receptor antagonist with >1400-fold selectivity[3] over the related vasopressin receptors -
Oxytocin antagonist
PF-3274167 is a high-affinity nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM. -
peptide Oxytocin Receptor Inhibitor
Atosiban is a peptide Oxytocin Receptor Inhibitor.- G Perez-Hernandez, .et al. , J Dairy Sci, 2023, Dec;106(12):9855-9867 PMID: 37641323
-
peripheral oxytocin receptors agonist
Carbetocin (Lonactene; Duratocin) is an obstetric drug used to control postpartum hemorrhage and bleeding after giving birth; an agonist at peripheral oxytocin receptors. -
oxytocin receptor antagonist
L-368,899 hydrochloride is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively, used as a tocolytic agent. -
Oxytocin antagonist
OT antagonist 1 (Compound 4) is a potent, selective Oxytocin antagonist with a Ki of 50 nM. -
oxytocin (OT) antagonist
OT antagonist 3 is an oxytocin (OT) antagonist extracted from patent WO2007017752A1. -
OT-R antagonist
OT-R antagonist 1 is a new potent and selective nonpeptide low molecular weight OT-R antagonist. -
OT-R antagonist
OT-R antagonist 2 is a nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 2 inhibitis IP3-Synthesis, rat OT-R (IC50 = 0.33 μM). -
oxytocin receptor ligand
Oxytocin (α-Hypophamine) acetate is a pleiotropic, hypothalamic peptide known for facilitating parturition, lactation, and prosocial behaviors. Oxytocin acetate can function as a stress-coping molecule with anti-inflammatory, antioxidant, and protective effects especially in the face of adversity or trauma.
